Table 4.
|
Comfort with HPV vaccine counseling (15 items)* |
|
||
---|---|---|---|---|
Characteristics | Pretest (mean score) |
Posttest (mean score) |
Mean difference (95% CI) |
p-value† |
Overall | 6.0 | 7.5 | 1.43 (0.75, 2.11) | 0.0002 |
Age | ||||
<30 | 6.0 | 7.5 | 1.43 (0.74, 2.13) | 0.0003 |
≥30 | 6.1 | 7.4 | 1.29 (−1.97, 4.54) | 0.47 |
Gender | ||||
Female | 6.2 | 7.5 | 1.32 (0.31, 2.34) | 0.004 |
Male | 5.9 | 7.4 | 1.51 (0.59, 2.43) | 0.02 |
Race/ethnicity | ||||
White | 6.0 | 6.8 | 0.79 (−0.19, 1.77) | 0.15 |
Asian | 6.0 | 8.9 | 2.85 (1.37, 4.33) | 0.0002 |
Hispanic | 5.1 | 7.2 | 2.09 (0.34, 3.85) | 0.03 |
Black/African | 7.0 | 6.9 | −0.14 (−2.60, 2.32) | 0.56 |
Other | 7.9 | 8.0 | 0.06 (−2.28, 2.41) | 0.93 |
HPV vaccine uptake | ||||
Yes | 6.0 | 6.9 | 0.87 (−0.13, 1.87) | 0.09 |
No | 6.2 | 8.0 | 1.78 (0.62, 2.95) | 0.01 |
CI = confidence interval.
*Mean scores calculated as an average of the total sum score (range = −15 to 15) for each participant on questions related to comfort with HPV vaccine counseling. Higher scores indicate greater readiness to counsel.
†Wilcoxon signed rank test with two-sided test.